247 related articles for article (PubMed ID: 17898269)
41. P63 expression in conjunctival proliferative diseases: pterygium and laryngo-onycho-cutaneous (LOC) syndrome.
Atkinson SD; Moore JE; Shah S; Sharma A; Best RM; Leccisotti A; Alarbi M; Rimmer D; Gardiner T; Moore TC
Curr Eye Res; 2008 Jul; 33(7):551-8. PubMed ID: 18600487
[TBL] [Abstract][Full Text] [Related]
42. Expression of vascular endothelial growth factor and inducible nitric oxide synthase in pterygia.
Lee DH; Cho HJ; Kim JT; Choi JS; Joo CK
Cornea; 2001 Oct; 20(7):738-42. PubMed ID: 11588427
[TBL] [Abstract][Full Text] [Related]
43. Study of substance P and its receptor neurokinin-1 in psoriasis and their relation to chronic stress and pruritus.
Remröd C; Lonne-Rahm S; Nordlind K
Arch Dermatol Res; 2007 May; 299(2):85-91. PubMed ID: 17370082
[TBL] [Abstract][Full Text] [Related]
44. Phospholipase D in the human ocular surface and in pterygium.
Tong L; Li J; Chew J; Tan D; Beuerman R
Cornea; 2008 Jul; 27(6):693-8. PubMed ID: 18580262
[TBL] [Abstract][Full Text] [Related]
45. The Ets-1 transcription factor is involved in pterygial angiogenesis.
Naib-Majani W; Breipohl W; Shazli EE; Theuerkauf I; Pleyer U; Hahne JC; Wernert N
Anat Histol Embryol; 2007 Apr; 36(2):107-10. PubMed ID: 17371382
[TBL] [Abstract][Full Text] [Related]
46. Expression of stem cell factor in pterygium.
Nakagami T; Watanabe I; Murakami A; Okisaka S; Ebihara N
Jpn J Ophthalmol; 2000; 44(3):193-7. PubMed ID: 10913635
[TBL] [Abstract][Full Text] [Related]
47. A role for the substance P/NK-1 receptor complex in cell proliferation and apoptosis in oral lichen planus.
González Moles MA; Esteban F; Ruiz-Avila I; Gil Montoya JA; Brener S; Bascones-Martínez A; Muñoz M
Oral Dis; 2009 Mar; 15(2):162-9. PubMed ID: 19036058
[TBL] [Abstract][Full Text] [Related]
48. Elevation of human alpha-defensins and S100 calcium-binding proteins A8 and A9 in tear fluid of patients with pterygium.
Zhou L; Beuerman RW; Ang LP; Chan CM; Li SF; Chew FT; Tan DT
Invest Ophthalmol Vis Sci; 2009 May; 50(5):2077-86. PubMed ID: 19168894
[TBL] [Abstract][Full Text] [Related]
49. Inhibitory effect of the substance P and its derivative on erythropoietin-independent growth of erythroid progenitors in polycythemia vera.
Le Gall C; Ianotto JC; Hardy E; Ugo V; Eveillard JR; Ngo-Sack F; Bourquard P; Morice P; Berthou C
Leuk Res; 2008 May; 32(5):743-54. PubMed ID: 17980427
[TBL] [Abstract][Full Text] [Related]
50. Observations favouring the occurrence of local production and marked effects of bombesin/gastrin-releasing peptide in the synovial tissue of the human knee joint--comparisons with substance P and the NK-1 receptor.
Grimsholm O; Rantapää-Dahlqvist S; Dalén T; Forsgren S
Neuropeptides; 2008 Apr; 42(2):133-45. PubMed ID: 18289674
[TBL] [Abstract][Full Text] [Related]
51. Modulation of cholesterol homeostasis by antiproliferative drugs in human pterygium fibroblasts.
Peiretti E; Dessì S; Mulas C; Abete C; Norfo C; Putzolu M; Fossarello M
Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3450-8. PubMed ID: 17652712
[TBL] [Abstract][Full Text] [Related]
52. [Fibroblasts from recurrent pterygium and normal Tenon's capsule exposed to tacrolimus (FK-506)].
Carvalho CS; Viveiros MM; Schellini SA; Candeias JM; Padovani CR
Arq Bras Oftalmol; 2007; 70(2):235-8. PubMed ID: 17589693
[TBL] [Abstract][Full Text] [Related]
53. Cyclooxygenase 2 expression in pterygium.
Chiang CC; Cheng YW; Lin CL; Lee H; Tsai FJ; Tseng SH; Tsai YY
Mol Vis; 2007 Apr; 13():635-8. PubMed ID: 17515883
[TBL] [Abstract][Full Text] [Related]
54. [Etiopathogenic aspects in development and evolution of pterigyum].
Crăiţoiu S; Ciprian L; Rodica M; Mihai A; Anca EI
Oftalmologia; 2008; 52(2):29-34. PubMed ID: 19065911
[TBL] [Abstract][Full Text] [Related]
55. Spatial association of prolyl oligopeptidase, inositol 1,4,5-triphosphate type 1 receptor, substance P and its neurokinin-1 receptor in the rat brain: an immunohistochemical colocalization study.
Myöhänen TT; Venäläinen JI; Garcia-Horsman JA; Männistö PT
Neuroscience; 2008 Jun; 153(4):1177-89. PubMed ID: 18455882
[TBL] [Abstract][Full Text] [Related]
56. Distribution of substance P and neurokinin-1 receptors in the peri-implant epithelium around titanium dental implants in rats.
Yamaza T; Kido MA; Wang B; Danjo A; Shimohira D; Murata N; Yoshinari M; Tanaka T
Cell Tissue Res; 2009 Feb; 335(2):407-15. PubMed ID: 19015883
[TBL] [Abstract][Full Text] [Related]
57. Neurokinin-1 receptor activation induces reactive oxygen species and epithelial damage in allergic airway inflammation.
Springer J; Groneberg DA; Dinh QT; Quarcoo D; Hamelmann E; Braun-Dullaeus RC; Geppetti P; Anker SD; Fischer A
Clin Exp Allergy; 2007 Dec; 37(12):1788-97. PubMed ID: 17941913
[TBL] [Abstract][Full Text] [Related]
58. Sensory neuropeptides are potent chemoattractants for human basophils in vitro.
Cima K; Vogelsinger H; Kähler CM
Regul Pept; 2010 Feb; 160(1-3):42-8. PubMed ID: 20035805
[TBL] [Abstract][Full Text] [Related]
59. Substance P is involved in the cutaneous blood flow increase response to sympathetic nerve stimulation in persistently inflamed rats.
Koeda T; Tamura R; Sato J; Mizumura K
J Physiol Sci; 2007 Dec; 57(6):361-6. PubMed ID: 18053315
[TBL] [Abstract][Full Text] [Related]
60. Unilateral intra-perilymphatic infusion of substance P enhances ipsilateral vestibulo-ocular reflex gains in the sinusoidal rotation test.
Orita H; Shimogori H; Yamashita H
Neurosci Lett; 2009 Jan; 449(3):207-10. PubMed ID: 19022352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
